Medical air
- Generic Name
- Medical air
- Drug Type
- Small Molecule
- CAS Number
- 132259-10-0
- Unique Ingredient Identifier
- K21NZZ5Y0B
- Background
Medical air is supplied by a special air compressor to patient care areas using clean outside air.
- Indication
For use as a source of clean air .
- Associated Conditions
- Hypoxia
Nitrous Oxide and EMOtional Cognition
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2024-08-29
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 84
- Registration Number
- NCT06557642
- Locations
- 🇬🇧
Psychiatry Department, Oxford, United Kingdom
Treatment of Suicidal Ideation in the Emergency Department Using Nitrous Oxide
- Conditions
- Emergency PsychiatricSuicidal IdeationNitrous Oxide
- Interventions
- First Posted Date
- 2024-05-28
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 30
- Registration Number
- NCT06430489
- Locations
- 🇫🇷
Psychiatric Emergencies, Tours, France
Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial-
- Conditions
- DepressionNeurocognitive Disorders
- Interventions
- Drug: EMONO
- First Posted Date
- 2024-04-24
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 96
- Registration Number
- NCT06382389
A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Duke University
- Target Recruit Count
- 10
- Registration Number
- NCT06327373
- Locations
- 🇺🇸
Davita Durham East, Durham, North Carolina, United States
🇺🇸Davita Research Triangle Park, Durham, North Carolina, United States
🇺🇸Davita Durham Downtown, Durham, North Carolina, United States
Effect of Nitrous Oxide on Aggression.
- Conditions
- Intermittent Explosive Disorder
- Interventions
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- Ohio State University
- Target Recruit Count
- 50
- Registration Number
- NCT06118567
- Locations
- 🇺🇸
Ohio State University Wexner Medical Center, Columbus, Ohio, United States
Hyperoxia Induced Pulmonary Inflammation and Organ Injury: a Human in Vivo Model
- Conditions
- Pulmonary InjuryAcute Lung InjuryOxygen Toxicity
- Interventions
- First Posted Date
- 2022-06-10
- Last Posted Date
- 2024-01-29
- Lead Sponsor
- Belfast Health and Social Care Trust
- Target Recruit Count
- 53
- Registration Number
- NCT05414370
- Locations
- 🇬🇧
Belfast Health and Social Care Trus, Belfast, United Kingdom
Supplemental Oxygen in Hypovolemia
- First Posted Date
- 2021-12-09
- Last Posted Date
- 2022-07-05
- Lead Sponsor
- Oslo University Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT05150418
- Locations
- 🇳🇴
Oslo University Hospital, Oslo, Norway
Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF).
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- First Posted Date
- 2021-09-22
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Dr. Denis O'Donnell
- Target Recruit Count
- 40
- Registration Number
- NCT05052229
- Locations
- 🇨🇦
Respiratory Investigation Unit, Kingston General Hospital, Kingston, Ontario, Canada
Nitrous Oxide for Late-Life Depression - PROTO-BRAIN
- Conditions
- Resistant Depression, TreatmentLate-Life Depression
- Interventions
- Drug: EMONO
- First Posted Date
- 2021-08-16
- Last Posted Date
- 2024-04-01
- Lead Sponsor
- University Hospital, Tours
- Target Recruit Count
- 60
- Registration Number
- NCT05007028
- Locations
- 🇫🇷
University Hospital of Tours, Tours, France
The Effect of Cooling on Sclerotherapy Efficacy
- First Posted Date
- 2020-12-31
- Last Posted Date
- 2021-01-05
- Lead Sponsor
- Goldman, Butterwick, Fitzpatrick and Groff
- Target Recruit Count
- 20
- Registration Number
- NCT04690803
- Locations
- 🇺🇸
West Dermatology Research Center/Cosmetic Laser Dermatology, San Diego, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.